Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.
about
The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestationsPharmacological interventions for somatoform disorders in adultsBulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromePsychological treatments for the management of irritable bowel syndromeClinical practice. Irritable bowel syndromeAn Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered MicrobiomeComponents of placebo effect: randomised controlled trial in patients with irritable bowel syndromeComplementary and alternative medicine for treatment of irritable bowel syndromeA controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndromeIrritable bowel syndrome: a concise review of current treatment conceptsAmitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome.Stress and visceral pain: from animal models to clinical therapiesAcceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trialNew directions in brain imaging research in functional gastrointestinal disorders.Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.Use of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled TrialsMindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial.Different faces of gastroparesis.Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessionsExpressive writing is a promising therapeutic modality for the management of IBS: a pilot study.Patient and practitioner influences on the placebo effect in irritable bowel syndromeCitalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders.A mixed methods feasibility study to evaluate the use of a low-intensity, nurse-delivered cognitive behavioural therapy for the treatment of irritable bowel syndromeCognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial.Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.The treatment of irritable bowel syndromeEffect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.Acupuncture treatment in irritable bowel syndromeA protocol for a trial of homeopathic treatment for irritable bowel syndrome.Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndromeEfficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel DiseasesReview article: current and emerging therapies for functional dyspepsia.The accuracy of patient-reported measures for GI symptoms: a comparison of real time and retrospective reportsA neurological approach to biopsychosocial medicine: Lessons from irritable bowel syndrome.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Antibiotics for irritable bowel syndrome: rationale and current evidence.
P2860
Q22001077-F590EC2C-2864-4831-A5C7-1153A07DE60EQ24201668-D01B5938-3857-499C-843C-02CA7E23F53EQ24234934-9713AC3A-E454-47A6-B677-671E2EA49753Q24241516-106A41C3-51B2-44B7-9D61-51191B411448Q24602718-131B6EFD-4268-45FB-97A8-FE81579532CAQ24630575-65513FD3-790E-4741-97E3-D7393EB8D8B6Q24647883-D83E4196-A8B7-49A2-9E4F-319E70D2B6E6Q24653574-2104C36F-3006-4323-B5BA-85A1E036AEE1Q24680181-71E1397A-BBBF-4DE3-B5F2-FBDC12BC5B8DQ26996547-D3DB84AA-7D4C-4DD5-A951-5A128BB197ACQ30350561-75D02A2E-6B77-44DF-8C90-32A96E9331BEQ30459512-BC943D4C-9EAE-4621-9380-E95C4FC63DF3Q31033578-BF400C6B-B7E4-4595-8197-B2901A400226Q31049096-B09D680D-242D-46ED-9BC5-38773A4A7AD5Q33449885-3A662DA5-214C-462E-A7A8-5C6AA0A902DFQ33467828-0D8B0F9D-8F60-49D9-9060-1C31AF3272ADQ33488090-7A2B2D3E-F690-4F9F-AB0D-9EDA254DD54DQ33555343-597AD553-4D5A-407D-A919-DF802B9EC218Q33580837-0763024A-7C8B-4E81-BA8B-3BEFC9C1D814Q33605649-BCE9CA52-4061-43A4-9558-0C054880A123Q33636363-888C5AD4-36E6-4927-B7DD-8D4AE634C6A8Q33636450-B7AA2ADA-D016-4366-AB7B-39A1729FD650Q33682414-E4A4192E-228E-4193-A9F2-EDBC60085A93Q33795765-F53D080A-E029-4B47-8D58-30FC1AB32FA6Q33920479-ED418DC6-B079-4629-959B-D8CBAFB3CF87Q34170707-C2AACA72-0300-4F2B-ADF5-5171E3C53684Q34318616-3C7B1BC9-1A7F-4B21-9FC9-147210C3FB3AQ34323319-52F3ABA8-49D1-455C-B17F-26AB2B02E151Q34409009-8A747713-634E-49F6-A1A0-243B3E2EDDFBQ34425086-318C700E-ED1D-437E-B467-456F79AE04DDQ34449406-7BDF3643-179F-4E28-A474-279CFC02E03DQ34468338-684D976C-BCC2-4636-8930-AA88CE9D7F86Q34483240-1D8A62D3-241C-4A3B-8D74-FA07F8CE5276Q34488657-BDB286D4-50E5-4013-BAB3-5A4C0CAAC400Q34549642-36D42612-A2CE-4445-BAF2-D3630087225BQ34553942-1356373B-9293-46A1-B0B9-04D699CAD81DQ34584523-E0E7B887-2507-43E7-8FB6-573A9AA8DD78Q34589513-626955AF-E6D9-48B4-9D2E-165B8DB9CEE4Q34626602-01913A0E-83B2-4627-9E02-98884A29F3E7Q34642080-62EA0CFC-C985-4B4A-AF9B-CAC0EBEB7B77
P2860
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@ast
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@en
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@nl
type
label
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@ast
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@en
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@nl
prefLabel
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@ast
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@en
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@nl
P2093
P1433
P1476
Cognitive-behavioral therapy v ...... re functional bowel disorders.
@en
P2093
Barbara Bradshaw
Brenda B Toner
Carlar J Blackman
Carolyn B Morris
Chris B Dalton
Donna Akman
Douglas A Drossman
Gary G Koch
Huanguang Jia
P356
10.1016/S0016-5085(03)00669-3
P407
P577
2003-07-01T00:00:00Z